We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
Cap. Flow
+$2.78B
Cap. Flow %
12.74%
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699

Sector Composition

Rank Sector Weight
1 Healthcare 20.03%
2 Consumer Discretionary 13.15%
3 Technology 10.68%
4 Financials 9.81%
5 Communication Services 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPLD icon
751
Upland Software
UPLD
$13.1M
$5.78M 0.03%
12,242
+2,513
+26% +$1.21M
GOOGL icon
752
PUT
Alphabet (Google) Class A
GOOGL
$3.99T
$5.78M 0.03%
+56,000
New +$5.53M
EWG icon
753
iShares MSCI Germany ETF
EWG
$1.55B
$5.77M 0.03%
+172,480
New +$5.63M
KAIR
754
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
$5.75M 0.03%
+590,533
New +$5.79M
NKE icon
755
PUT
Nike
NKE
$62.5B
$5.74M 0.03%
+43,200
New +$6.01M
SHACU
756
DELISTED
SCP & CO Healthcare Acquisition Company Unit
SHACU
$5.72M 0.03%
+573,794
New +$5.84M
MKTX icon
757
MarketAxess Holdings
MKTX
$4.19B
$5.71M 0.03%
11,476
+4,627
+68% +$2.47M
SJR
758
DELISTED
Shaw Communications Inc.
SJR
$5.69M 0.03%
218,928
-36,299
-14% -$717K
ANF icon
759
Abercrombie & Fitch
ANF
$4.41B
$5.69M 0.03%
165,879
+100,600
+154% +$2.77M
DNLI icon
760
Denali Therapeutics
DNLI
$3.74B
$5.68M 0.03%
+99,518
New +$6.66M
FVRR icon
761
Fiverr
FVRR
$398M
$5.67M 0.03%
26,135
+24,220
+1,265% +$5.94M
ABMD
762
DELISTED
Abiomed Inc
ABMD
$5.67M 0.03%
17,783
+14,394
+425% +$4.61M
DNMR.WS
763
CALL
DELISTED
Danimer Scientific, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class
DNMR.WS
$5.66M 0.03%
+150,000
New +$3.77M
MAXR
764
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$5.64M 0.03%
149,156
+132,066
+773% +$5.88M
RKLBW
765
CALL
DELISTED
Rocket Lab USA, Inc. Warrant
RKLBW
$5.62M 0.03%
474,972
+208,311
+78% +$471K
SKIL icon
766
Skillsoft
SKIL
$58.9M
$5.58M 0.03%
27,918
-2,509
-8% -$513K
DUK icon
767
Duke Energy
DUK
$100B
$5.57M 0.03%
57,727
+51,254
+792% +$4.68M
CG icon
768
Carlyle Group
CG
$16.7B
$5.56M 0.03%
151,366
+45,827
+43% +$1.61M
EL icon
769
Estee Lauder
EL
$30.1B
$5.56M 0.03%
+19,131
New +$5.24M
PSX icon
770
Phillips 66
PSX
$83.3B
$5.54M 0.03%
+67,974
New +$5.33M
B
771
Barrick Mining
B
$62.6B
$5.54M 0.03%
279,183
-571,775
-67% -$12.3M
CARR icon
772
Carrier Global
CARR
$57.6B
$5.54M 0.03%
131,090
-171,394
-57% -$6.66M
PASG icon
773
Passage Bio
PASG
$14.8M
$5.52M 0.03%
+15,794
New +$6.74M
KRTX
774
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$5.51M 0.03%
+45,861
New +$5.2M
THMAU
775
DELISTED
Thimble Point Acquisition Corp. Unit
THMAU
$5.5M 0.03%
+550,200
New +$5.62M

Similar funds

Marshall Wace's Q1 2021 Portfolio in Review

As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.

  • Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
  • Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
  • Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
  • Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
  • Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
  • Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.

Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.